Trovagene Inc (TROV) Stock Price, Quote, News and Overview
NASDAQ:TROV - Nasdaq -
TROV Quote, Performance and Key Statistics
1.19
-0.01 (-0.83%)
The current stock price of TROV is 1.19 null. In the past month the price increased by 47.08%. In the past year, price decreased by -62.34%.
About TROV
Company Profile
Trovagene is a clinical-stage, oncology therapeutics company, taking a precision cancer medicine approach to develop drugs that target mitosis (cell division) to treat various types of cancer, including leukemias, lymphomas and solid tumors. Trovagene has intellectual property and proprietary technology that enables the Company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics.
Company Info
Trovagene Inc
11055 FLINTKOTE AVENUE
SAN DIEGO CA 92121
CEO: Thomas H. Adams
Phone: 858-952-7570
Trovagene Inc / TROV FAQ
What is the stock price of Trovagene Inc today?
The current stock price of TROV is 1.19 null. The price decreased by -0.83% in the last trading session.
What is the ticker symbol for Trovagene Inc stock?
The exchange symbol of Trovagene Inc is TROV and it is listed on the Nasdaq exchange.
On which exchange is TROV stock listed?
TROV stock is listed on the Nasdaq exchange.
What is Trovagene Inc worth?
Trovagene Inc (TROV) has a market capitalization of 13.10M null. This makes TROV a Nano Cap stock.
What are the support and resistance levels for Trovagene Inc (TROV) stock?
Trovagene Inc (TROV) has a support level at 0.86 and a resistance level at 1.26. Check the full technical report for a detailed analysis of TROV support and resistance levels.
Should I buy Trovagene Inc (TROV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TROV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TROV, evaluating the profitability, health, valuation and growth aspects
- Trovagene Inc (TROV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Trovagene Inc (TROV) Sales and EPS estimates to see what analysts future expectations are.
- Trovagene Inc (TROV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Trovagene Inc (TROV) Insider and Institutional Ownership to learn about the owners and their transactions.
- Trovagene Inc (TROV) Stock Chart to make your own analysis
- Trovagene Inc (TROV) Latest news and press-releases to stay up to date.
Does Trovagene Inc (TROV) stock pay dividends?
TROV does not pay a dividend.
What is the Price/Earnings (PE) ratio of Trovagene Inc (TROV)?
Trovagene Inc (TROV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.8).
TROV Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TROV. When comparing the yearly performance of all stocks, TROV is a bad performer in the overall market: 85.67% of all stocks are doing better.
TROV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TROV. TROV may be in some trouble as it scores bad on both profitability and health.
TROV Financial Highlights
Over the last trailing twelve months TROV reported a non-GAAP Earnings per Share(EPS) of -2.8. The EPS increased by 66.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -4732.65% | ||
| ROA | -140.47% | ||
| ROE | N/A | ||
| Debt/Equity | 0.11 |
TROV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to TROV. The Buy consensus is the average rating of analysts ratings from 2 analysts.